Longato, E., Camillo, B. D., Sparacino, G., Tramontan, L., Avogaro, A., & Fadini, G. P. (2021). Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: A region-wide retrospective study. BMC.
Cita Chicago Style (17a ed.)Longato, Enrico, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, y Gian Paolo Fadini. Cardiovascular Outcomes After Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-wide Retrospective Study. BMC, 2021.
Cita MLA (8a ed.)Longato, Enrico, et al. Cardiovascular Outcomes After Initiating GLP-1 Receptor Agonist or Basal Insulin for the Routine Treatment of Type 2 Diabetes: A Region-wide Retrospective Study. BMC, 2021.